AdaptHealth director buys 20,000 shares at $6.30

AdaptHealth Corp. director Dale B. Wolf reported an amended Form 4 reflecting the correct pricing for a recent share purchase.

Rhea-AI Filing Summary

AdaptHealth Corp. director Dale B. Wolf reported an amended Form 4 reflecting the correct pricing for a recent share purchase. On 2026-08-06, he purchased 20,000 shares of common stock in open-market or private transactions at an average price of $6.30 per share, with individual trade prices ranging from $6.26 to $6.335. Following these transactions, he directly holds 143,234 shares of AdaptHealth common stock and indirectly holds 34,000 shares through the Dale B. Wolf Generation Skipping Trust, for which he serves as investment manager.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 2 txns

Insider WOLF DALE B

Role Director

Bought 20,000 shs ($126K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	20,000	$6.30	$126K
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 143,234 shares (Direct); Common Stock — 34,000 shares (Indirect, By Trust)

Footnotes (2)

1. F1. The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
2. F2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Key Figures

Shares purchased: 20,000 shares Average purchase price: $6.30 per share Trade price range: $6.26–$6.335 per share +2 more

5 metrics

Shares purchased 20,000 shares Common stock purchased on 2026-08-06

Average purchase price $6.30 per share Reported average for the 20,000-share purchase

Trade price range $6.26–$6.335 per share Prices of multiple transactions for the 20,000 shares

Direct holdings after transaction 143,234 shares Direct AdaptHealth common stock held by Dale B. Wolf

Indirect holdings via GST 34,000 shares Shares held by the Dale B. Wolf Generation Skipping Trust

Key Terms

Generation Skipping Trust, indirect ownership, open market or private transaction

3 terms

Generation Skipping Trust financial

"Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST")."

indirect ownership financial

"total_shares_following_transaction": "34000.0000" ... "ownership_type": "indirect""

open market or private transaction financial

"transaction_code_description": "Purchase in open market or private transaction""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AdaptHealth (AHCO) director Dale B. Wolf report in this amended Form 4?

Dale B. Wolf reported an amended Form 4 for a 20,000-share purchase of AdaptHealth common stock. The amendment corrects pricing details while confirming his updated direct and indirect share holdings in the company.

How many AdaptHealth (AHCO) shares did Dale B. Wolf buy and at what price range?

Dale B. Wolf bought 20,000 shares of AdaptHealth common stock on 2026-08-06. Trades were executed at prices ranging from $6.26 to $6.335 per share, with an average reported price of $6.30.

What are Dale B. Wolf’s direct AdaptHealth (AHCO) holdings after this transaction?

After the reported purchase, Dale B. Wolf directly holds 143,234 shares of AdaptHealth common stock. This figure represents his personal direct ownership position as reported following the 20,000-share acquisition.

What indirect AdaptHealth (AHCO) holdings does Dale B. Wolf report?

Dale B. Wolf indirectly holds 34,000 shares of AdaptHealth common stock through the Dale B. Wolf Generation Skipping Trust. He is the investment manager of this trust, and these holdings are reported as indirect ownership.

Why was this AdaptHealth (AHCO) Form 4 amended?

The Form 4 was amended to report the correct pricing of the shares purchased. The amendment clarifies that the 20,000 shares were acquired in multiple transactions at prices between $6.26 and $6.335 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:05 PM Accepted by SEC EDGAR 08/14/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/10/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2026		P		20,000	A	$6.3(1)	143,234	D
Common Stock								34,000	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Dale Wolf	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)